INSTITUT PASTEUR
Patent Owner
Stats
- 450 US PATENTS IN FORCE
- 24 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 450 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 9,538 Total Citation Count
- Sep 29, 1975 Earliest Filing
- 656 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0008,723 MULTIMERIC COMPOUNDS OF A KRINGLE DOMAIN FROM THE HEPATOCYTE GROWTH FACTOR / SCATTER FACTOR (HGF/SF)Jan 21, 16Jan 11, 18[A61K, G01N]
2017/0369,888 ADAM12 Inhibitors and Their Use Against Inflammation-Induced FibrosisAug 29, 17Dec 28, 17[A61K, C12Q, C12N, G01N, A01K]
2017/0362,607 USE OF NON-SUBTYPE B GAG PROTEINS FOR LENTIVIRAL PACKAGINGAug 10, 17Dec 21, 17[C12N, C07K]
2017/0354,709 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEDec 23, 15Dec 14, 17[A61K]
2017/0334,975 POLYCLONAL ANTIBODIES SPECIFIC FOR SEROGROUP X OF N. MENINGITIDIS AND USES THEREOF IN DIAGNOSISNov 17, 15Nov 23, 17[G01N, C07K]
2017/0326,246 CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO AN ANIONIC POLYPEPTIDE FOR THE TREATMENT OF AIDSOct 23, 15Nov 16, 17[A61K, C07K]
2017/0327,572 TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ANTAGONISM OF THE IL-20RNov 23, 15Nov 16, 17[A61K, C07K]
2017/0238,556 INSECTICIDE PROPERTIES OF AN EXTRACT OF SEXTONIA RUBRA, AND THE CONSTITUENTS THEREOFSep 22, 15Aug 24, 17[A01N]
2017/0212,113 PREDICTIVE VALUE OF CLOSTRIDIUM DIFFICILE-SPECIFIC IMMUNE RESPONSE FOR RECURRENCE AND DISEASE OUTCOMEApr 01, 15Jul 27, 17[A61K, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9919029 Methods and pharmaceutical compositions for the treatment of bacterial infectionsJul 25, 14Mar 20, 18[A61K]
9913829 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compoundJul 29, 11Mar 13, 18[A61K]
9914937 Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositionsMar 24, 15Mar 13, 18[A61K, C12N, C07K]
9907860 Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to an anionic polypeptide for the treatment of AIDSOct 23, 15Mar 06, 18[A61K, C07K]
9894888 Transgenic immunodeficient mouse expressing human SIRP-alphaMar 26, 13Feb 20, 18[C12N, A01K, G01N, C07K]
9889193 Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyJan 20, 14Feb 13, 18[A61K, C12N]
9868989 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detectionSep 18, 15Jan 16, 18[C12Q]
9839683 Vaccine for prophylaxis or treatment of an allergen-driven airway pathologyJan 30, 15Dec 12, 17[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0182,077 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedFeb 13, 15Jun 29, 17[A61K, C07K]
2016/0217,250 IDENTIFYING MOLECULAR SYSTEMS IN PROTEIN SEQUENCE DATAAbandonedJan 27, 15Jul 28, 16[G06F, C40B]
2016/0166,646 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedJun 27, 14Jun 16, 16[A61K]
2016/0047,810 METHODS TO OBTAIN A NOVEL CLASS OF GRAM NEGATIVE BACTERIA ANTIBIOTICS WHICH TARGET AN UNKNOWN CELL DIVISION ASSOCIATED PROTEIN LOP1AbandonedApr 08, 14Feb 18, 16[C12Q, C12N, G01N, C07K]
2015/0343,018 NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLSAbandonedOct 03, 13Dec 03, 15[A61K, G01N]
2015/0246,095 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZAAbandonedOct 01, 13Sep 03, 15[A61K, C12Q, G01N]
2015/0224,129 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA WITH INVARIANT NKT CELL AGONISTSAbandonedOct 01, 13Aug 13, 15[A61K]
2015/0168,399 MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECTAbandonedFeb 13, 15Jun 18, 15[G01N]
2015/0071,873 Cancer Treatment by Immunotherapy With BCG or Antigenically Related Non-Pathogenic MycobacteriaAbandonedJan 24, 13Mar 12, 15[A61K, G01N]
2014/0336,126 OPTINEURIN-DERIVED POLYPEPTIDES, THEIR NUCLEIC ACIDS AND USES THEREOFAbandonedDec 18, 12Nov 13, 14[G01N, C07K]
2014/0294,791 Lactobacillus paracasei subsp. paracasei, as an agent for inhibiting listeria monocytogenes in vivo infectionAbandonedDec 01, 11Oct 02, 14[A61K, A23L]
2014/0206,081 VARIABLE DOMAINS OF CAMELID HEAVY-CHAIN ANTIBODIES DIRECTED AGAINST GLIAL FIBRILLARY ACIDIC PROTEINSAbandonedMay 08, 13Jul 24, 14[C12N]
2014/0193,843 USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKERAbandonedFeb 14, 14Jul 10, 14[G01N]
2014/0154,289 ATTENUATED PLASMODIUM WITH DEACTIVATED HMGB2 GENE, AS VACCINEAbandonedJul 19, 12Jun 05, 14[A61K]
2014/0088,184 Use of Epigallocatechin Gallate as an Antiviral Agent against infections by the Hepatitis C VirusAbandonedMar 28, 12Mar 27, 14[A61K]
8563008 Polynucleotides and polypeptides involved in gestational malaria, and biological applicationsExpiredApr 17, 08Oct 22, 13[A61K, C07H, C07K]
8551500 Composition comprising the N-terminal region of histone H2B of leishmania—use thereof for inducing an immune responseExpiredMay 08, 08Oct 08, 13[A61K]
8541206 Differential amplification of mutant nucleic acids by PCR in a mixture of nucleic acidsExpiredDec 28, 06Sep 24, 13[C12P]
8481486 Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-RExpiredSep 15, 08Jul 09, 13[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
